Key Points
- Patrick Stewart died at 86, and his family disclosed that he had Alzheimer's disease and Lewy body dementia, diagnoses not previously made public.
- Lewy body dementia is the second most common neurodegenerative dementia in the U.S., affecting more than 1 million people, yet it is frequently mistaken for Alzheimer's or Parkinson's disease.
- No single test can diagnose it in living patients, and overlapping symptoms — plus coexisting Alzheimer's pathology in 30% to 60% of autopsy cases — make early recognition a persistent clinical challenge.
What Patrick Stewart's Death Revealed About Lewy Body Dementia
Patrick Stewart, the classically trained stage actor who became a household name through the Star Trek franchise and the X-Men films, died at 86, his family announced Thursday. His spokesperson described a brief and poignant journey with Alzheimer's disease and Lewy body dementia — diagnoses that had not been disclosed while he was alive, according to the Associated Press.
The disclosure matters beyond the obituary pages. Alzheimer's disease is the most common form of dementia in the United States, affecting more than 7 million Americans. Lewy body dementia is the second most common neurodegenerative dementia, affecting more than 1 million people — a figure that experts say is easy to underestimate because the condition is so often overlooked or mistaken for Alzheimer's or Parkinson's disease.
Lewy body dementia is an umbrella term covering two related disorders: dementia with Lewy bodies and Parkinson's disease dementia. Both involve abnormal clumps of a protein called alpha-synuclein, known as Lewy bodies, which are also associated with Parkinson's. There is no single test that can confirm the diagnosis in a living person. Instead, clinicians must assemble a picture from symptoms that can include memory and problem-solving deficits, hallucinations and delusions, slow or rigid movement, balance problems, sleep disorders such as restless leg syndrome and dream enactment, anxiety, depression, and autonomic dysfunction. Loss of smell is often an early sign.
Because those symptoms overlap with other neurodegenerative conditions, the diagnostic process can be slow and frustrating for patients and families. Michael Okun, MD, of the University of Florida Fixel Institute, told MedPage Today that awareness matters because recognizing the diagnosis early can change care, safety, and quality of life for families. Melissa Armstrong, MD, MSc, also of the University of Florida, said that in her early research interviewing former caregivers, more than a third of participants raised misdiagnosis, delays, or conflicting diagnoses even when asked specifically about the end of life.
At a Glance
| Main Figure | Patrick Stewart Classically trained stage and screen actor, known for Star Trek and X-Men, who died at age 86. |
| Condition | Lewy body dementia Umbrella term covering dementia with Lewy bodies and Parkinson's disease dementia; second most common neurodegenerative dementia in the U.S. |
| Coexisting Condition | Alzheimer's disease Most common U.S. dementia, affecting more than 7 million Americans; Stewart was reported to have both. |
| Key Biological Marker | Alpha-synuclein Protein forming the abnormal clumps called Lewy bodies; also linked to Parkinson's disease. |
| Affected Population | More than 1 million Americans Estimated number living with Lewy body dementia in the U.S. |
| Diagnostic Constraint | No single confirmatory test Diagnosis in living patients relies on assembling multiple clinical clues rather than one test. |
| Expert Source | Michael Okun, MD University of Florida Fixel Institute; cited on the importance of early recognition for care and safety. |
| Expert Source | Melissa Armstrong, MD, MSc University of Florida; cited on misdiagnosis and diagnostic delay in caregiver research. |
| Notable Precedent | Robin Williams Actor who developed Lewy body disease; his widow, Susan Schneider Williams, wrote about the diagnostic ordeal. |
Why Lewy Body Dementia Keeps Slipping Through the Diagnostic Net
Why the Diagnosis Is So Hard to Pin Down
The clinical difficulty is structural, not incidental. Dementia with Lewy bodies requires clinicians to combine disparate clues — cognitive fluctuation, visual hallucinations, dream enactment, parkinsonian movement symptoms — into a single judgment. Armstrong noted that key clues such as dream enactment may simply be missed, while hallucinations may be misattributed to a psychiatric condition such as schizophrenia. There is no single test to settle the question in a living patient, so the diagnosis depends on how well those pieces are gathered and weighed.
The Overlap With Alzheimer's Complicates the Picture
Adding to the challenge, abnormal alpha-synuclein and Alzheimer's pathology can coexist in the same brain. About 30% to 60% of Alzheimer's autopsy cases show concurrent alpha-synuclein pathology, which may affect outcomes. For families, the result is often a long period of uncertainty before a name is put to the condition — many, on first hearing "Lewy body dementia," say something like "we knew something was different."
What Awareness Actually Changes
Okun's point is that recognition is not an academic exercise: an earlier, more accurate diagnosis can change care, safety, and quality of life for families. That has practical consequences for how symptoms are triaged, how medications are chosen, and how households plan for progression. The condition is not rare in older adults, he added, and the field needs better recognition, better tools, and more open conversations about hallucinations, dream enactment, and fluctuating thinking.
The Precedent Behind the Current Attention
This is not the first time a high-profile death has pushed Lewy body dementia into public view. Susan Schneider Williams wrote in a Neurology essay about her husband, actor and comedian Robin Williams, who developed Lewy body disease and died by suicide — an account that highlighted how disorienting the diagnostic process can be for families. Stewart's case adds another prominent name to that list, and with it another opening for clinicians and advocacy groups to press the case for earlier identification.
Where the Pressure Lands
For health systems and neurology practices, the story reinforces a familiar operational problem: the conditions most likely to be missed are the ones that require time, cross-specialty input, and careful history-taking. For families, the message is that an unexplained mix of memory, movement, sleep, and behavioral symptoms is worth pursuing rather than accepting a single, premature label.
What Families and Clinicians Should Take From This Case
The single most important point: Lewy body dementia is common enough — over 1 million Americans — that a cluster of memory, movement, sleep, and behavioral symptoms should prompt a deliberate diagnostic workup, not a default assumption of Alzheimer's or a psychiatric cause.
- If a family member shows dream enactment (acting out dreams), visual hallucinations, fluctuating alertness, or parkinsonian stiffness alongside memory changes, raise the possibility of Lewy body dementia explicitly with the clinician — Armstrong's research found misdiagnosis and diagnostic delay were persistent themes even in end-of-life caregiver interviews.
- Do not accept a schizophrenia or purely psychiatric label without a neurological review; Armstrong noted hallucinations are sometimes misattributed that way.
- Ask whether loss of smell, restless leg symptoms, or autonomic problems have been documented — these are the kinds of clues that can be missed when visits focus on cognition alone.
- For clinicians: Okun's framing is that early recognition changes care, safety, and quality of life, so building a routine that captures sleep and movement symptoms alongside cognitive testing is the practical lever.
Comments 0